Catalyst Wire Dossier Catalyst Wire Dossier

Paliperidone palmitate (Invega Sustenna)

paliperidone palmitate · Janssen Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Paliperidone palmitate (Invega Sustenna), covering 2025-09-29 to 2025-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics in Schizophrenia [Phase 4]

See pricing